Orbita Symposium
Munich 2023

Test

Thursday, November 23, 2023

9.00 am Welcome
9.00 am – 10.20 am Diagostics/Clinic/Imaging
„The algorithm is seeing you now”-Systematic approach to exophthalmos
and update on automated diagnosis making
U. Schaudig
Ophthalmology meets Radiology: Common language or Babylon
U. Müller-Lisse
Hertel-Exophthalmometry and beyond
A. Klingenstein
MRI-Imaging of the orbit: T1, T2 and what else?
U. Müller-Lisse
Role of DOTA-TATE PET in managing orbital disease
A. Klingenstein
10.20 am – 11.00 am Coffee break
11.00 am – 14.30 pm Orbital lesions I
The problems of how to treat adenoid cystic carcinoma: why we should generally avoid exenteration
G. Rose
Update on capillary haemangioas
L. Baldeschi
Surgical treatment of orbital vascular anomalies
M. Sales Sanz
Update on orbital meningioma treatment
C. Schichor
VEXAS Syndrome
M. Sales Sanz
Orbital metastases
R. Allen
12.30 pm – 1.30 pm Lunch break
A rationale approach to orbital surgery, routes to different orbital compartment
L. Baldeschi
Endonasal orbital approaches: Options and risks
F. Haubner
Use of 3D technology in Oculoplastic and Orbital surgery
D. Briscoe
2.30 pm – 4.30 pm Socket
Short introduction into socket issues
C. Hintschich
Orbital Implants after Enucleation/Evisceration – a German data base
A. Schuh
Adequate volume replacement – how we got it wrong in the past
G. Rose
Dermofat grafting: The Munich experience
A. Schuh
Relining of the whole socket – the „Chevron graft“ technique
G. Rose
Artificial eye: Critical review of different materials
B. Zimmermann
Use of temporalis muscle flap in an ophthalmic socket reconstruction
M. Sales Sanz
4.30 pm – 5.00 pm Coffee break
5.00 pm – 5.45 pm Interactive work-shop
Analizing orbital imaging: Radiological differential diagnosis?
U. Müller-Lisse & Panel

Friday, November 24, 2023

8.30 am – 12.00 am Thyroid Eye Disease
Evaluation: what really counts
A. Eckstein
Risk factors for Graves´ Disease – an update
R. Gärtner
Diagnosing TED-CON: Are we missing something?
A. Garip-Kübler
Neurofilaments as a tool to detect Optic Neuropathy in TED patients
D. Briscoe
Latest news on OCT & OCT-Angio
A. Garip-Kübler
Targeted therapies – theory and practice
A. Eckstein
Treating TED in the US in the time of teprotumumab
R. Allen
10.30 am – 11.00 am Coffee break
Optimal decompression in Thyroid Orbitopathy
D. Briscoe
Orbital decompression: Tips and tricks
L. Baldeschi
Functional outcome ofter decompression surgery
C. Hintschich
Q&A/discussion
222
12.00 am – 1.00 pm Lunch break
1.00 pm – 2.20 pm Orbital lesions II
Typical benign and malignant tumors of childhood
L. Baldeschi
Pediatric orbital inflammation
R. Allen
Rare Soft Tissue Tumors of the Orbit
D. Briscoe
Solitary fibrous tumors: results of a monocenter study
A. Eckstein
New treatment strategies: Checkpoint Inhibitors
V. Schmelter
IgG4 – what is it all about?
G. Rose
2.45 pm – 3.15 pm Coffee break
3.15 pm – 4.30 pm Cases
Tracing unknows
G. Rose, U Schaudig, U Mueller-Lisse & colleagues